Chronic alcohol abuse and the acute sedative and neurophysiologic effects of midazolam

Lance O. Bauer, Jeffrey B. Gross, Roger Meyer, David J. Greenblatt

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The aim of the present investigation was to examine benzodiazepine sensitivity in abstinent alcoholics. For this purpose, two escalating doses of the benzodiazepine midazolam were IV administered to nine alcohol-dependent patients after 2-3 weeks of abstinence and 12 healthy, non-alcoholic volunteers. A variety of dependent measures were examined, including the power spectrum of the resting electroencephalogram (EEG) and evoked EEG responses, saccadic eye movements, self-reported sedation, and vigilance task performance. Analyses revealed a significant association between plasma midazolam levels and changes in EEG beta power, pattern shift visual evoked potential amplitude, heart rate, and saccade amplitude and velocity. The patient and control groups differed significantly in the onset latencies of their saccadic eye movements, and marginally in EEG beta power, both before and after midazolam. However, no differences were detected between the groups in the dose of midazolam required to produce sedation or in midazolam's neurophysiological effects.

Original languageEnglish (US)
Pages (from-to)293-299
Number of pages7
JournalPsychopharmacology
Volume133
Issue number3
DOIs
StatePublished - Oct 28 1997

Fingerprint

Midazolam
Hypnotics and Sedatives
Alcoholism
Saccades
Electroencephalography
Benzodiazepines
Visual Evoked Potentials
Task Performance and Analysis
Alcoholics
Volunteers
Heart Rate
Alcohols
Control Groups
Power (Psychology)

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Bauer, Lance O. ; Gross, Jeffrey B. ; Meyer, Roger ; Greenblatt, David J. / Chronic alcohol abuse and the acute sedative and neurophysiologic effects of midazolam. In: Psychopharmacology. 1997 ; Vol. 133, No. 3. pp. 293-299.
@article{f955b271a40e43399e00f494f2d5158d,
title = "Chronic alcohol abuse and the acute sedative and neurophysiologic effects of midazolam",
abstract = "The aim of the present investigation was to examine benzodiazepine sensitivity in abstinent alcoholics. For this purpose, two escalating doses of the benzodiazepine midazolam were IV administered to nine alcohol-dependent patients after 2-3 weeks of abstinence and 12 healthy, non-alcoholic volunteers. A variety of dependent measures were examined, including the power spectrum of the resting electroencephalogram (EEG) and evoked EEG responses, saccadic eye movements, self-reported sedation, and vigilance task performance. Analyses revealed a significant association between plasma midazolam levels and changes in EEG beta power, pattern shift visual evoked potential amplitude, heart rate, and saccade amplitude and velocity. The patient and control groups differed significantly in the onset latencies of their saccadic eye movements, and marginally in EEG beta power, both before and after midazolam. However, no differences were detected between the groups in the dose of midazolam required to produce sedation or in midazolam's neurophysiological effects.",
author = "Bauer, {Lance O.} and Gross, {Jeffrey B.} and Roger Meyer and Greenblatt, {David J.}",
year = "1997",
month = "10",
day = "28",
doi = "10.1007/s002130050404",
language = "English (US)",
volume = "133",
pages = "293--299",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "3",

}

Chronic alcohol abuse and the acute sedative and neurophysiologic effects of midazolam. / Bauer, Lance O.; Gross, Jeffrey B.; Meyer, Roger; Greenblatt, David J.

In: Psychopharmacology, Vol. 133, No. 3, 28.10.1997, p. 293-299.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Chronic alcohol abuse and the acute sedative and neurophysiologic effects of midazolam

AU - Bauer, Lance O.

AU - Gross, Jeffrey B.

AU - Meyer, Roger

AU - Greenblatt, David J.

PY - 1997/10/28

Y1 - 1997/10/28

N2 - The aim of the present investigation was to examine benzodiazepine sensitivity in abstinent alcoholics. For this purpose, two escalating doses of the benzodiazepine midazolam were IV administered to nine alcohol-dependent patients after 2-3 weeks of abstinence and 12 healthy, non-alcoholic volunteers. A variety of dependent measures were examined, including the power spectrum of the resting electroencephalogram (EEG) and evoked EEG responses, saccadic eye movements, self-reported sedation, and vigilance task performance. Analyses revealed a significant association between plasma midazolam levels and changes in EEG beta power, pattern shift visual evoked potential amplitude, heart rate, and saccade amplitude and velocity. The patient and control groups differed significantly in the onset latencies of their saccadic eye movements, and marginally in EEG beta power, both before and after midazolam. However, no differences were detected between the groups in the dose of midazolam required to produce sedation or in midazolam's neurophysiological effects.

AB - The aim of the present investigation was to examine benzodiazepine sensitivity in abstinent alcoholics. For this purpose, two escalating doses of the benzodiazepine midazolam were IV administered to nine alcohol-dependent patients after 2-3 weeks of abstinence and 12 healthy, non-alcoholic volunteers. A variety of dependent measures were examined, including the power spectrum of the resting electroencephalogram (EEG) and evoked EEG responses, saccadic eye movements, self-reported sedation, and vigilance task performance. Analyses revealed a significant association between plasma midazolam levels and changes in EEG beta power, pattern shift visual evoked potential amplitude, heart rate, and saccade amplitude and velocity. The patient and control groups differed significantly in the onset latencies of their saccadic eye movements, and marginally in EEG beta power, both before and after midazolam. However, no differences were detected between the groups in the dose of midazolam required to produce sedation or in midazolam's neurophysiological effects.

UR - http://www.scopus.com/inward/record.url?scp=0030756287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030756287&partnerID=8YFLogxK

U2 - 10.1007/s002130050404

DO - 10.1007/s002130050404

M3 - Article

C2 - 9361336

AN - SCOPUS:0030756287

VL - 133

SP - 293

EP - 299

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 3

ER -